UT Southwestern research into mechanisms of neurodegenerative disease takes center stage

Through the generous support of the Winspear Family Center for Research on the Neuropathology of Alzheimer's Disease, the Alzheimer's Disease Center at UT Southwestern is providing videos of all lectures from its symposium on the mechanisms of neurodegenerative diseases. The symposium was held in February of 2012 and featured a multidisciplinary group of researchers at UT Southwestern.

Click on lecture title for video

Opening Remarks with Roger Rosenberg, M.D., and Greg Fitz, M.D.

James Malter, M.D.: How amyloid is processed and metabolized at the synapse

Bruce Beutler, M.D.: Inflammation and how it works as a cause of neurodegenerative disease

Philipp Scherer, Ph.D.: Energy machinery of mitochondria and problems with energy generation in Alzheimer’s disease

Andrew Pieper, M.D., Ph.D.: Potential protection therapy developed with Steve McKnight, Ph.D.

Ilya Bezprozvanny, Ph.D.: Interrelationships of presenilins, calcium signaling and Alzheimer’s disease

Roger Rosenberg, M.D.: Update on a preventive therapy for Alzheimer’s -- a DNA vaccine that would lead to the removal of brain-accumulated amyloid

Gang Yu, Ph.D.: Biology of frontotemporal dementia and potential new therapies

Craig Powell, M.D., Ph.D.: Relationship between autism and degeneration of synaptic function

Weichun Lin, Ph.D.: Regulation of synapse formation by ApoE receptors and the amyloid precursor protein

Joachim Herz, M.D.: Therapeutics for neurodegenerative disease

Opening Remarks: Roger Rosenberg, M.D. and Greg Fitz, M.D.

Return to Top

Bruce Beutler, M.D.: Inflammation and how it works as a cause of neurodegenerative disease

Return to Top

Andrew Pieper, M.D., Ph.D.: Neuroprotective therapy for neurodegenerative disease

Return to Top

Roger Rosenberg, M.D.: Update on a preventive therapy for Alzheimer’s – a DNA vaccine that would lead to the removal of brain-accumulated amyloid

Return to Top

Craig Powell, M.D., Ph.D.: Relationship between autism and degeneration of synaptic function

Return to Top

Joachim Herz, M.D.: Therapeutics for neurodegenerative disease

Return to Top

James Malter, M.D.: How amyloid is processed and metabolized at the synapse

Return to Top

Philipp Scherer, Ph.D.: Energy machinery of mitochondria and problems with energy generation in Alzheimer’s disease

Return to Top

Ilya Bezprozvanny, Ph.D.: Interrelationships of presenilins, calcium signaling, and Alzheimer’s disease

Return to Top

Gang Yu, Ph.D.: Biology of frontotemporal dementia and potential new therapies

Return to Top

Weichun Lin, Ph.D.: Regulation of synapse formation by ApoE receptors and the amyloid precursor protein

Return to Top

Share: